Novartis

Performance, Capabilities, Goals and Strategies in The Worldwide Pharmaceutical Market

Publication Date	September 2009
Publisher	Venture Planning Grp.
Product Type	Report
Pages	121
ISBN Number	not applicable
Product Code	VEP00260

Buy this product or for assistance call +44 20 7060 7474

PDF £1,140.00$1896 | €1276

FAX Order above formats by FAX

Summary

A strategic assessment of Novartis, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market.

Content

I. Executive Summary
II. Business Organization
III. Senior Management
IV. Facilities and Employees
V. Technological Know-How
VI. Product Portfolio
VII. Marketing Tactics
VIII. Sales and Profit Growth
IX. R&D Expenditures and Major Programs
X. Collaborative Arrangements
XI. Strategic Direction
List of Tables
- Table 1: Novartis Sales and Operating Profit Growth
- Table 2: Novartis Sales by Business Segment
- Table 3: Novartis Sales Growth by Business Segment
- Table 4: Novartis Operating Profit by Business Segment
- Table 5: Novartis Operating Profit Growth by Business Segment
- Table 6: Novartis Sales by Country
- Table 7: Novartis Sales Growth by Country
- Table 8: Novartis Sales by Therapeutic Category
- Table 9: Novartis Sales Growth by Therapeutic Category
- Table 10: Novartis Sales of Top 20 Drugs
- Table 11: Novartis Sales Growth by Major Drug